IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAVAZZANA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.541
EU - Europa 7.090
AS - Asia 4.603
SA - Sud America 966
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 22.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.384
IT - Italia 3.881
SG - Singapore 1.617
CN - Cina 1.563
UA - Ucraina 928
BR - Brasile 826
DE - Germania 616
HK - Hong Kong 503
VN - Vietnam 317
FI - Finlandia 300
GB - Regno Unito 295
FR - Francia 236
IE - Irlanda 227
RU - Federazione Russa 219
TR - Turchia 181
IN - India 125
CA - Canada 82
BD - Bangladesh 69
AR - Argentina 61
SE - Svezia 59
NL - Olanda 54
AT - Austria 41
ZA - Sudafrica 41
MX - Messico 40
ES - Italia 39
IQ - Iraq 35
PL - Polonia 33
JP - Giappone 32
BE - Belgio 27
EE - Estonia 23
EC - Ecuador 21
ID - Indonesia 21
RO - Romania 20
LT - Lituania 19
MA - Marocco 19
PK - Pakistan 18
AE - Emirati Arabi Uniti 16
SA - Arabia Saudita 15
VE - Venezuela 15
JO - Giordania 13
CH - Svizzera 12
EG - Egitto 12
KE - Kenya 12
UZ - Uzbekistan 12
KZ - Kazakistan 11
PY - Paraguay 11
IL - Israele 10
EU - Europa 9
AU - Australia 8
CZ - Repubblica Ceca 8
UY - Uruguay 8
AZ - Azerbaigian 7
CO - Colombia 7
MK - Macedonia 7
CL - Cile 6
JM - Giamaica 6
LU - Lussemburgo 6
PA - Panama 6
PE - Perù 6
TT - Trinidad e Tobago 6
IR - Iran 5
KG - Kirghizistan 5
AL - Albania 4
GR - Grecia 4
HN - Honduras 4
LV - Lettonia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LI - Liechtenstein 3
MU - Mauritius 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
KR - Corea 2
LK - Sri Lanka 2
NP - Nepal 2
TH - Thailandia 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GT - Guatemala 1
Totale 22.301
Salva come PNG Salva come JPEG
Città #
Fairfield 1.061
Woodbridge 800
Ashburn 732
Singapore 724
Jacksonville 680
Houston 577
Hong Kong 502
Beijing 424
Seattle 423
Cambridge 418
Wilmington 415
Ann Arbor 377
Princeton 310
Milan 285
Chandler 280
Los Angeles 254
New York 248
Nanjing 224
Chicago 209
Rome 199
Helsinki 177
Dublin 165
The Dalles 153
Istanbul 146
Brescia 126
Ho Chi Minh City 117
Florence 104
Dallas 103
Buffalo 94
Munich 91
Moscow 88
Des Moines 87
Nanchang 84
Salt Lake City 82
San Diego 67
São Paulo 66
Hebei 64
Redondo Beach 64
Hanoi 60
Shenyang 60
Turin 60
San Francisco 58
Lancaster 57
Trieste 55
Verona 55
Changsha 54
Tianjin 49
Bologna 47
London 45
Jinan 43
Shanghai 43
Jiaxing 39
Genoa 38
Dearborn 35
Elk Grove Village 34
Udine 34
Brooklyn 33
Tampa 33
Padova 32
Tokyo 31
Turku 30
Toronto 28
Brussels 27
Nuremberg 26
Rio de Janeiro 26
Phoenix 25
Genova 24
Kunming 24
Mumbai 24
Pisa 24
Santa Clara 23
Tallinn 23
Bergamo 22
Belo Horizonte 21
Johannesburg 21
Modena 21
Syracuse 21
Vienna 21
Atlanta 20
Frankfurt am Main 20
Hangzhou 20
Menlo Park 20
Warsaw 20
Falkenstein 19
Guangzhou 18
Montreal 18
Ningbo 18
Reggio Nell'emilia 18
Chennai 17
Torino 17
Miami 16
Naples 16
Redwood City 16
Trento 16
Bari 15
Palermo 15
Dhaka 14
Orem 14
Taizhou 14
Zhengzhou 14
Totale 12.821
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.338
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.767
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 684
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 200
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 194
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 186
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 176
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 169
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 169
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 165
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 164
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 163
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 159
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 158
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 156
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 155
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 155
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 152
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 151
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 151
The clinico-serological spectrum of overlap myositis 150
Autoimmune polyendocrine Syndromes 149
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 147
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 147
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 146
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 143
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 142
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 140
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 138
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 134
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 133
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 132
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 132
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 130
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 130
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 129
Endothelium and the brain in CNS lupus. 129
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 128
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 128
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 127
Anti-Ro/SSA and La/SSB antibodies 127
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 126
Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? 126
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 126
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 126
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 124
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 122
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 121
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 119
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 118
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 117
Complement Activation and Pregnancy Failure. 116
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 116
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 114
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 114
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 114
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 114
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 113
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 113
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 113
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 112
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 112
Update on Antiphospholipid Syndrome: Ten Topics in 2017 112
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 111
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 111
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 111
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 111
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 111
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 110
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 110
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 110
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 110
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 109
Cardiological features in idiopathic inflammatory myopathies. 108
Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations 108
Serologic profile and mortality rates of scleroderma renal crisis in Italy 108
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 108
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 107
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 106
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 106
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 105
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 105
Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. 104
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 104
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 104
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 104
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 103
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 103
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 103
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 103
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 103
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 102
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 100
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 99
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 99
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 98
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 98
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 97
Comparison of early and late onset systemic lupus erythematosus 97
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 96
Totale 16.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.678 0 0 0 0 0 281 119 271 312 286 281 128
2021/20221.997 113 248 112 106 116 147 151 154 135 195 180 340
2022/20231.482 207 26 45 64 115 331 36 164 257 50 102 85
2023/20241.543 81 52 120 121 86 278 82 68 330 58 62 205
2024/20254.119 70 75 59 366 368 358 262 159 354 317 853 878
2025/20264.010 632 976 510 925 631 336 0 0 0 0 0 0
Totale 22.609